Risk factors for overuse injuries in a cohort of elite Swedish track and field athletes

Table 5 Movement, clinical and strength variables in athletes with thigh/hip injuries and athletes without thigh/hip injuries

	Group	n	p	r_pb	m	SD
Movement
HAD_{ROM_R [°]}	Inj	15	.16	.24	4.68	2.38
HAD_{ROM_R [°]}	No	66			5.80	2.58
HAD_{ROM_L [°]}	Inj	15	.13	.25	4.19	2.01
HAD_{ROM_L [°]}	No	66			5.21	2.44
KF_{VEL_R [°/s]}	Inj	15	.08	.29	257.82	41.53
KF_{VEL_R [°/s]}	No	66			360.59	161.28
KF_{VEL_L [°/s]}	Inj	15	.03*	.37	266.14	42.50
KF_{VEL_L [°/s]}	No	66			367.97	152.16
AEV_{_R [°]}	Inj	15	.70	−.07	14.86	5.61
AEV_{_R [°]}	No	66			15.78	7.66
AEV_{_L [°]}	Inj	15	.53	−.11	15.24	5.06
AEV_{_L [°]}	No	66			15.67	7.51
AEV_{VEL_R [°/s]}	Inj	15	.88	−.03	245.12	88.32
AEV_{VEL_R [°/s]}	No	66			266.10	133.35
AEV_{VEL_L [°/s]}	Inj	15	.64	−.08	250.26	84.70
AEV_{VEL_L [°/s]}	No	66			262.72	134.95
Clinical
RF_{FLEX_R [°]}	Inj	17	.30	.16	140.77	8.48
RF_{FLEX_R [°]}	No	73			140.74	15.62
RF_{FLEX_L [°]}	Inj	17	.82	.04	148.94	5.80
RF_{FLEX_L [°]}	No	73			149.25	10.11
IL_{FLEX_R [°]}	Inj	17	.17	−.21	108.77	11.46
IL_{FLEX_R [°]}	No	78			107.40	10.66
IL_{FLEX_L [°]}	Inj	17	.15	−.23	111.25	8.61
IL_{FLEX_L [°]}	No	78			110.65	8.65
Strength
HAB:HAD _[Nm/kg]	Inj	16	.25	.15	0.76	0.08
HAB:HAD _[Nm/kg]	No	79			0.82	0.21
H:Q_{_R [Nm/kg]}	Inj	17	.62	.08	0.79	0.15
H:Q_{_R [Nm/kg]}	No	77			0.84	0.16
H:Q_{_L [Nm/kg]}	Inj	17	.84	.03	0.80	0.12
H:Q_{_L [Nm/kg]}	No	77			0.83	0.15

HAD_ROM Hip adduction range of motion, KF_VEL Knee flexion velocity, AEV Ankle eversion, AEV_VEL Ankle eversion velocity, RF_FLEX Rectus femoris flexibility, IL_FLEX Iliopsoas flexibility, HAB:HAD Hip abduction:adduction strength ratio, H:Q Hamstring:quadriceps strength ratio, R Right side, L Left side, n number, * indicates p ≤ 0.05, r_pb Rank-Biserial Correlation, m Mean, SD Standard deviation, 95% CI Confidence interval

ISSN: 2052-1847